FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
FDA approves new Alzheimer's drug, Kinsula, offering hope to Pensacola patients
It's not a cure-- but it is a step in the right direction.This month-- a new medication for alzheimer's, called 'kinsul'a, was approved by the
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite the recent approval, Eli Lilly's stock isn't skyrocketing.
The FDA approves new Alzheimer's drug; calling it a breakthrough
"Every step forward brings us a little bit closer to a world without Alzheimer's," said Beth Sulkowski, Alzheimer's Association SC VP of communications.
Third FDA-approved Alzheimer’s drug can give patients more time with family
Alzheimer’s patients can temporarily lessen their symptoms with a recent FDA-approved drug that removes amyloid, or protein, plaques in the brain.
FDA approves a second Alzheimer’s drug that can slow the disease by several months
U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
New Alzheimer’s treatment approved by US FDA
LOS ANGELES - The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment from American pharmaceutical company Eli Lilly, the drugmaker said recentlly. The drug donanemab will be sold under the brand name Kisunla for adults with early symptomatic Alzheimer's disease,
Everything You Need to Know About Kisunla, The New FDA-Approved Alzheimer's Drug
The latest drug is showing promising results for adults with early Alzheimer's symptoms, mild cognitive impairment (MCI), and mild dementia stages of the disease.
NPR16d
FDA approves a second Alzheimer's drug that can modestly slow disease
The FDA approved Kisunla, known chemically as donanemab ... aren’t yet setup to prescribe the new plaque-targeting Alzheimer's drugs. First, doctors need to confirm that patients with ...
Fox News16d
FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’
The U.S. Food and Drug Administration (FDA) has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults ...
The Washington Post16d
FDA approves Eli Lilly Alzheimer’s drug after months of delay
Kisunla — which was approved for treatment of early symptomatic Alzheimer’s disease — doesn’t ... Kisunla is the third amyloid-targeting drug to win the FDA’s blessing since 2021 ...
The Hill16d
FDA approves Lilly’s new Alzheimer’s drug after delay
The FDA approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way for another entry into the market of a new class of drugs that moderately slows the disease’s ...